SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-014403
Filing Date
2023-08-10
Accepted
2023-08-10 07:36:21
Documents
40
Period of Report
2023-08-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K apre-20230810x8k.htm   iXBRL 8-K 41592
2 EX-99.1 apre-20230810xex99d1.htm EX-99.1 129092
3 EX-99.2 apre-20230810xex99d2.htm EX-99.2 39258
4 GRAPHIC apre-20230810xex99d2g001.jpg GRAPHIC 77393
5 GRAPHIC apre-20230810xex99d2g002.jpg GRAPHIC 393069
6 GRAPHIC apre-20230810xex99d2g003.jpg GRAPHIC 201537
7 GRAPHIC apre-20230810xex99d2g004.jpg GRAPHIC 150474
8 GRAPHIC apre-20230810xex99d2g005.jpg GRAPHIC 186543
9 GRAPHIC apre-20230810xex99d2g006.jpg GRAPHIC 67463
10 GRAPHIC apre-20230810xex99d2g007.jpg GRAPHIC 157600
11 GRAPHIC apre-20230810xex99d2g008.jpg GRAPHIC 148153
12 GRAPHIC apre-20230810xex99d2g009.jpg GRAPHIC 161493
13 GRAPHIC apre-20230810xex99d2g010.jpg GRAPHIC 151509
14 GRAPHIC apre-20230810xex99d2g011.jpg GRAPHIC 173057
15 GRAPHIC apre-20230810xex99d2g012.jpg GRAPHIC 177217
16 GRAPHIC apre-20230810xex99d2g013.jpg GRAPHIC 196302
17 GRAPHIC apre-20230810xex99d2g014.jpg GRAPHIC 204727
18 GRAPHIC apre-20230810xex99d2g015.jpg GRAPHIC 68322
19 GRAPHIC apre-20230810xex99d2g016.jpg GRAPHIC 113979
20 GRAPHIC apre-20230810xex99d2g017.jpg GRAPHIC 136774
21 GRAPHIC apre-20230810xex99d2g018.jpg GRAPHIC 119236
22 GRAPHIC apre-20230810xex99d2g019.jpg GRAPHIC 66041
23 GRAPHIC apre-20230810xex99d2g020.jpg GRAPHIC 212705
24 GRAPHIC apre-20230810xex99d2g021.jpg GRAPHIC 74313
25 GRAPHIC apre-20230810xex99d2g022.jpg GRAPHIC 142010
26 GRAPHIC apre-20230810xex99d2g023.jpg GRAPHIC 176932
27 GRAPHIC apre-20230810xex99d2g024.jpg GRAPHIC 125804
28 GRAPHIC apre-20230810xex99d2g025.jpg GRAPHIC 77393
  Complete submission text file 0001558370-23-014403.txt   5543550

Data Files

Seq Description Document Type Size
29 EX-101.SCH apre-20230810.xsd EX-101.SCH 3900
30 EX-101.DEF apre-20230810_def.xml EX-101.DEF 2845
31 EX-101.LAB apre-20230810_lab.xml EX-101.LAB 17246
32 EX-101.PRE apre-20230810_pre.xml EX-101.PRE 11356
34 EXTRACTED XBRL INSTANCE DOCUMENT apre-20230810x8k_htm.xml XML 4859
Mailing Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902
Business Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 267-370-5219
Aprea Therapeutics, Inc. (Filer) CIK: 0001781983 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39069 | Film No.: 231157199
SIC: 2834 Pharmaceutical Preparations